In the Research Article “Pregnancy and Infant Outcomes in Multiple Sclerosis: Findings From the Global MAPLE-MS Pharmacovigilance Program” by Hellwig et al.,1 the Article Processing Charge funding statement should be as follows: “The Article Processing Charge was funded by the healthcare business of Merck KGaA, Darmstadt, Germany.” The authors regret the error.
Reference
- 1.Hellwig K, Tilson HH, Thiel S, et al. Pregnancy and infant outcomes in multiple sclerosis: findings from the Global MAPLE-MS pharmacovigilance program. Neurol Neuroimmunol Neuroinflamm. 2025;12(5):e200438. doi: 10.1212/NXI.0000000000200438 [DOI] [PMC free article] [PubMed] [Google Scholar]